Which medications treat wet macular degeneration?
ANSWER
Medications, such as Avastin, Eylea, Lucentis, and Macugen have become the preferred treatments for acute wet macular degeneration, helping to prevent the growth of leaky blood vessels in your eye. Lucentis is given once every month, although some patients may need treatment only once every three months. Macugen is given every six weeks. Eylea is given once every two months after three once-monthly injections. Avastin is not strictly an eye medication, but it is used off-label as one of the most common treatments for wet macular degeneration.
Reviewed by Alan Kozarsky on July 13, 2017
SOURCES:
News release, FDA.
James B. , Blackwell Publishing, 2003. Lecture Notes on Ophthalmology
Macular Degeneration Partnership.
Pfizer: “Macugen Description.”
American Academy of Ophthalmology: "Preferred Practice Pattern, Age Related Macular Degeneration."
National Institutes of Health: "NIH study provides clarity on supplements for protection against blinding eye disease."
SOURCES:
News release, FDA.
James B. , Blackwell Publishing, 2003. Lecture Notes on Ophthalmology
Macular Degeneration Partnership.
Pfizer: “Macugen Description.”
American Academy of Ophthalmology: "Preferred Practice Pattern, Age Related Macular Degeneration."
National Institutes of Health: "NIH study provides clarity on supplements for protection against blinding eye disease."
THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.
This tool does not provide medical advice. See additional information.